| Clinicopathological features, treatment approaches, and outcomes in Rosai-Dorfman disease G Goyal, A Ravindran, JR Young, MV Shah, NN Bennani, MM Patnaik, ... haematologica 105 (2), 348, 2020 | 135 | 2020 |
| consensus statement for the diagnosis and evaluation of adult patients with histiocytic neoplasms: Erdheim-Chester disease, Langerhans cell histiocytosis, and Rosai-Dorfman disease G Goyal, JR Young, MJ Koster Mayo Clin Proc 94 (10), 2054-2071, 2019 | 130 | 2019 |
| International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults G Goyal, A Tazi, RS Go, KL Rech, JL Picarsic, R Vassallo, JR Young, ... Blood, The Journal of the American Society of Hematology 139 (17), 2601-2621, 2022 | 103 | 2022 |
| The Mayo Clinic Histiocytosis Working Group consensus statement for the diagnosis and evaluation of adult patients with histiocytic neoplasms: Erdheim-Chester disease … G Goyal, JR Young, MJ Koster, WO Tobin, R Vassallo, JH Ryu, ... Mayo Clinic Proceedings 94 (10), 2054-2071, 2019 | 102 | 2019 |
| 18F-FDG PET/CT in Erdheim–Chester Disease: Imaging Findings and Potential BRAF Mutation Biomarker JR Young, GB Johnson, RC Murphy, RS Go, SM Broski Journal of Nuclear Medicine 59 (5), 774-779, 2018 | 60 | 2018 |
| Frequency and Characteristics of Nodal and Deltoid FDG and 11C-Choline Uptake on PET Performed After COVID-19 Vaccination DG Schroeder, S Jang, DR Johnson, H Takahashi, PJ Navin, SM Broski, ... American Journal of Roentgenology 217 (5), 1206-1216, 2021 | 40 | 2021 |
| Rheumatoid pulmonary nodules: clinical and imaging features compared with malignancy M Koslow, JR Young, SY Eunhee, M Baqir, PA Decker, GB Johnson, ... European radiology 29 (4), 1684-1692, 2019 | 39 | 2019 |
| How We Do It: A Multidisciplinary Approach to 177Lu DOTATATE Peptide Receptor Radionuclide Therapy BJ Burkett, A Dundar, JR Young, AT Packard, GB Johnson, ... Radiology 298 (2), 261-274, 2021 | 34 | 2021 |
| Efficacy of BRAF‐Inhibitor Therapy in BRAFV600E‐Mutated Adult Langerhans Cell Histiocytosis AZ Hazim, GJ Ruan, A Ravindran, JP Abeykoon, C Scheckel, R Vassallo, ... The Oncologist 25 (12), 1001-1004, 2020 | 30 | 2020 |
| Single-agent cladribine as an effective front-line therapy for adults with Langerhans cell histiocytosis G Goyal, JP Abeykoon, M Hu, JR Young, MV Shah, NN Bennani, TG Call, ... American journal of hematology 96 (5), E146, 2021 | 23 | 2021 |
| Metabolic characteristics and prognostic differentiation of aggressive lymphoma using one-month post-CAR-T FDG PET/CT WG Breen, MA Hathcock, JR Young, RO Kowalchuk, R Bansal, ... Journal of hematology & oncology 15 (1), 36, 2022 | 22 | 2022 |
| Outcomes after treatment with Cobimetinib in patients with Rosai-Dorfman disease based on kras and mek alteration status JP Abeykoon, KL Rech, JR Young, A Ravindran, GJ Ruan, S Dasari, ... JAMA oncology 8 (12), 1816-1820, 2022 | 19 | 2022 |
| Langerhans cell histiocytosis with lung involvement in isolation and multisystem disease: Staging, natural history, and comparative survival AZ Hazim, GJ Ruan, M Hu, A Ravindran, KL Rech, JR Young, CW Cox, ... American Journal of Hematology 96 (12), 1604-1610, 2021 | 19 | 2021 |
| Analysis and impact of a multidisciplinary lymphoma virtual tumor board TM Habermann, A Khurana, R Lentz, JJ Schmitz, AG von Bormann, ... Leukemia & Lymphoma 61 (14), 3351-3359, 2020 | 15 | 2020 |
| Adult Langerhans cell histiocytosis: A contemporary single-institution series of 186 patients. G Goyal, M Hu, JR Young, R Vassallo, JH Ryu, NN Bennani, MV Shah, ... Journal of Clinical Oncology 37 (15_suppl), 7018-7018, 2019 | 15 | 2019 |
| Sustained, complete response to pexidartinib in a patient with CSF1R‐mutated Erdheim–Chester disease JP Abeykoon, TL Lasho, S Dasari, KL Rech, WK Ranatunga, MK Manske, ... American Journal of Hematology 97 (3), 293-302, 2022 | 12 | 2022 |
| Unusual manifestations of diffuse-type tenosynovial giant cell tumor in two patients: importance of radiologic-pathologic correlation A Dundar, JR Young, DE Wenger, CY Inwards, SM Broski Skeletal Radiology 49, 483-489, 2020 | 11 | 2020 |
| Skeletal metastasis evaluation: value and impact of PET/computed tomography on diagnosis, management and prognosis SM Broski, JR Young, AT Kendi, RM Subramaniam PET clinics 14 (1), 103-120, 2019 | 11 | 2019 |
| Persistent mediastinal FDG uptake on PET-CT after frontline therapy for Hodgkin lymphoma: biopsy, treat or observe? M Novo, GS Nowakowski, TM Habermann, TE Witzig, IN Micallef, ... Leukemia & Lymphoma 61 (2), 318-327, 2020 | 10 | 2020 |
| Successful treatment of non-Langerhans cell histiocytosis with the MEK inhibitor trametinib: a multicenter analysis A Aaroe, R Kurzrock, G Goyal, AM Goodman, H Patel, G Ruan, G Ulaner, ... Blood Advances 7 (15), 3984-3992, 2023 | 9 | 2023 |
